Skip to content

NTHI NTHI Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.1B-43.5%
Pfizer logo
PfizerPFE
$2.62B+12.0%
Merck & Co. logo
Merck & Co.MRK
$3.92B+56.7%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
-$6.51M-56.0%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$32.44M+0.3%
Nuvation Bio logo
Nuvation BioNUVB
$5.07M+112%

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's operating cash flow?
NTHI (NTHI) reported operating cash flow of -$6.99M in Q1 2026.
How has NTHI's operating cash flow changed year-over-year?
NTHI's operating cash flow decreased by 23.7% year-over-year, from -$5.65M to -$6.99M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.